MCSSX | VSTSX | MCSSX / VSTSX | |
Total Expense Ratio | 1.15 | 0.01 | 11,500% |
Annual Report Gross Expense Ratio | 1.15 | 0.01 | 11,500% |
Fund Existence | 17 years | 9 years | - |
Gain YTD | 2.578 | 1.376 | 187% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 507M | 1.82T | 0% |
Annual Yield % from dividends | 0.00 | 1.29 | - |
Returns for 1 year | 7.76 | 10.09 | 77% |
Returns for 3 years | 37.86 | 57.70 | 66% |
Returns for 5 years | 68.13 | 91.51 | 74% |
Returns for 10 years | 95.70 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MCLOX | 17.07 | -0.13 | -0.76% |
BlackRock Global Allocation Inv C | |||
OGICX | 38.13 | -0.37 | -0.96% |
Invesco Global Opportunities C | |||
ETHSX | 12.98 | -0.13 | -0.99% |
Eaton Vance Worldwide Health Sci A | |||
WINDX | 33.27 | -0.39 | -1.16% |
FT Wilshire 5000 Index Instl | |||
GFVCX | 14.99 | -0.20 | -1.32% |
Goldman Sachs Focused Value C |